| Financial Year |
March 31 2023 |
| Monetary Funds |
755,266,389.56 |
| Held-for-trading Financial Assets |
917,385,742.46 |
| Notes Receivable |
-- |
| Accounts Receivable |
21,865,305.54 |
| Advances to Suppliers |
5,251,653.23 |
| Other Receivables |
30,293,692.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
389,322,908.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
51,854,748.38 |
| Other Current Assets |
9,097,664.78 |
| Total Current Assets |
2,180,338,105.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
787,724,332.98 |
| Investment Properties |
27,455,635.89 |
| Fixed Assetes |
76,750,862.34 |
| Under-construction Projects |
178,841,396.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
112,789,440.19 |
| R&D expenses |
-- |
| Goodwill |
7,657,909.93 |
| Long-Term Deferred and Prepaid Expenses |
11,700,045.15 |
| Deferred Income Tax Assets |
33,063,625.50 |
| Other Non-Current Assets |
1,895,649.67 |
| Sub-Total of Non-Current Assets |
1,239,190,449.70 |
| Total Assets |
3,419,528,555.35 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
30,256,391.35 |
| Accounts Received In Advance |
1,042,057.08 |
| Employee Compensation Payable |
25,511,400.34 |
| Taxes Payable |
100,706,315.27 |
| Interest Payable |
-- |
| Dividend Payable |
12,452,215.21 |
| Other payables |
197,725,446.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
857,077.82 |
| Other Current Liabilities |
352,764.04 |
| Sub-Total of Current Liabilities |
363,076,111.96 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
27,218,094.84 |
| Deferred Income Tax Liabilities |
309,870.66 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
27,865,356.91 |
| Total Liabilities |
390,941,468.87 |
| Paid-In Capital(Or Share Stock) |
988,828,300.00 |
| Capital Surplus |
956,947,441.79 |
| Surplus Reserve |
405,001,761.79 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
673,847,722.09 |
| Minority Stockholder's Interest |
6,195,384.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,022,391,702.16 |
| Owner's Equity（Stockholder's Equity） |
3,028,587,086.48 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,419,528,555.35 |
